600521 华海药业
已收盘 04-29 15:00:00
资讯
新帖
简况
华海药业最新公告:一季度净利润2.71亿元 同比增加56.62%
证券之星 · 20:30
华海药业最新公告:一季度净利润2.71亿元 同比增加56.62%
华海药业最新公告:2023年净利润8.3亿元 同比减少28.88%
证券之星 · 20:30
华海药业最新公告:2023年净利润8.3亿元 同比减少28.88%
华海药业(600521.SH)发布一季度业绩,净利润2.71亿元 同比增加56.62%
智通财经 · 19:41
华海药业(600521.SH)发布一季度业绩,净利润2.71亿元 同比增加56.62%
华海药业(600521.SH)发布2023年度业绩,净利润8.3亿元 同比减少28.88%
智通财经 · 19:39
华海药业(600521.SH)发布2023年度业绩,净利润8.3亿元 同比减少28.88%
华海药业:一季度净利润2.71亿元 同比增长56.62%
证券时报网 · 18:51
华海药业:一季度净利润2.71亿元 同比增长56.62%
华海药业最新公告:下属子公司获得注射用HB0052药物临床试验许可
证券之星 · 17:47
华海药业最新公告:下属子公司获得注射用HB0052药物临床试验许可
华海药业04月29日获主力加仓1217万元 环比增加1154.64%
自选股智能写手 · 15:17
华海药业04月29日获主力加仓1217万元 环比增加1154.64%
北向资金4月25日净买入华海药业5.75万股 连续3日增持
自选股智能写手 · 04-26
北向资金4月25日净买入华海药业5.75万股 连续3日增持
华海药业04月24日遭主力抛售2595万元 环比增加921.65%
自选股智能写手 · 04-24
华海药业04月24日遭主力抛售2595万元 环比增加921.65%
华海药业(600521.SH)获“白消安注射液”药品注册证书
智通财经 · 04-23
华海药业(600521.SH)获“白消安注射液”药品注册证书
华海药业最新公告:获得白消安注射液药品注册证书
证券之星 · 04-23
华海药业最新公告:获得白消安注射液药品注册证书
超级真菌概念盘中跳水,海正药业跌0.80%
自选股智能写手 · 04-18
超级真菌概念盘中跳水,海正药业跌0.80%
华海药业(600521.SH)获得托拉塞米片药品注册证书
智通财经网 · 04-16
华海药业(600521.SH)获得托拉塞米片药品注册证书
华海药业04月16日遭主力抛售3115万元 环比增加775.00%
自选股智能写手 · 04-16
华海药业04月16日遭主力抛售3115万元 环比增加775.00%
高血压概念盘中拉升,华海药业涨1.22%
自选股智能写手 · 04-16
高血压概念盘中拉升,华海药业涨1.22%
华海药业:预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元
证券之星 · 04-15
华海药业:预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元
华海药业(600521.SH):2023年度净利润8.26亿元 同比下降29.25%
智通财经网 · 04-15
华海药业(600521.SH):2023年度净利润8.26亿元 同比下降29.25%
华海药业(600521.SH):2023年净利润同比下降29.25%
格隆汇资讯 · 04-15
华海药业(600521.SH):2023年净利润同比下降29.25%
华海药业(600521.SH):恩格列净片获得药品注册证书
格隆汇资讯 · 04-15
华海药业(600521.SH):恩格列净片获得药品注册证书
公司概况
公司名称:
浙江华海药业股份有限公司
所属行业:
医药制造业
上市日期:
2003-03-04
主营业务:
浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月,公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”,同月,公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地;2023年6月,公司入选米内网颁发的2022年度中国化药企业百强等。
发行价格:
15.55
{"stockData":{"symbol":"600521","market":"SH","secType":"STK","nameCN":"华海药业","latestPrice":16.11,"timestamp":1714374000000,"preClose":16.05,"halted":0,"volume":16375403,"delay":0,"floatShares":1467000000,"shares":1483000000,"eps":0.6263,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"04-29 15:00:00","open":16.09,"high":16.35,"low":16,"amount":264000000,"amplitude":0.0218,"askPrice":16.11,"askSize":80,"bidPrice":16.1,"bidSize":234,"shortable":0,"etf":0,"ttmEps":0.6263,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714440600000},"adr":0,"adjPreClose":16.05,"symbolType":"stock","openAndCloseTimeList":[[1714354200000,1714361400000],[1714366800000,1714374000000]],"highLimit":17.66,"lowLimit":14.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1482507145,"pbRate":3.05,"roa":"--","roe":"9.14%","epsLYR":0.57,"committee":-0.09582,"marketValue":23883000000,"floatMarketCap":23629000000,"peRate":25.722498,"changeRate":0.0037,"turnoverRate":0.0112,"status":0},"requestUrl":"/m/hq/s/600521/wiki","defaultTab":"wiki","newsList":[{"id":"2431085136","title":"华海药业最新公告:一季度净利润2.71亿元 同比增加56.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431085136","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431085136?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:30","pubTimestamp":1714393817,"startTime":"0","endTime":"0","summary":"华海药业发布2024年一季度报告,报告期内公司实现营业收入24.99亿元,同比增加21.36%;归属于上市公司股东的净利润2.71亿元,同比增加56.62%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900029624.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431851323","title":"华海药业最新公告:2023年净利润8.3亿元 同比减少28.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431851323","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431851323?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:30","pubTimestamp":1714393805,"startTime":"0","endTime":"0","summary":"华海药业发布2023年度业绩报告,报告期内公司实现营业收入83.09亿元,同比增加0.52%;归属于上市公司股东的净利润8.3亿元,同比减少28.88%。公司拟向全体股东每10股派送现金红利2元(含税)。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900029623.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431858578","title":"华海药业(600521.SH)发布一季度业绩,净利润2.71亿元 同比增加56.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431858578","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431858578?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:41","pubTimestamp":1714390895,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)发布2024年一季度报告,报告期内公司实现营业收入24.99亿元,同比增加21.36%;归属于上市公司股东的净利润2.71亿元,同比增加56.62%;归属于上市公司股东的扣除非经常性损益的净利润3.15亿元,同比增加67.29%;基本每股收益0.19元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114795.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431585857","title":"华海药业(600521.SH)发布2023年度业绩,净利润8.3亿元 同比减少28.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431585857","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431585857?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:39","pubTimestamp":1714390781,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)发布2023年度业绩报告,报告期内公司实现营业收入83.09亿元,同比增加0.52%;归属于上市公司股东的净利润8.3亿元,同比减少28.88%;归属于上市公司股东的扣除非经常性损益的净利润8.89亿元,同比减少25.96%;基本每股收益0.57元,公司拟向全体股东每 10 股派送现金红利 2 元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114787.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431318398","title":"华海药业:一季度净利润2.71亿元 同比增长56.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431318398","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2431318398?lang=zh_cn&edition=full","pubTime":"2024-04-29 18:51","pubTimestamp":1714387860,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,华海药业(600521)4月29日晚间披露一季报,公司2024年一季度实现营业收入24.99亿元,同比增长21.36%;净利润2.71亿元,同比增长56.62%;基本每股收益0.19元。公司同日公告,下属子公司华奥泰及华博生物近日收到国家药监局核准签发的注射用HB0052的《药物临床试验批准通知书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042918521687bee35e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042918521687bee35e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431805958","title":"华海药业最新公告:下属子公司获得注射用HB0052药物临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2431805958","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431805958?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:47","pubTimestamp":1714384051,"startTime":"0","endTime":"0","summary":"华海药业公告,下属子公司华奥泰及华博生物获得注射用HB0052药物临床试验许可。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900023105.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431006565","title":"华海药业04月29日获主力加仓1217万元 环比增加1154.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431006565","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431006565?lang=zh_cn&edition=full","pubTime":"2024-04-29 15:17","pubTimestamp":1714375059,"startTime":"0","endTime":"0","summary":"04月29日, 华海药业股价涨0.37%,报收16.11元,成交金额2.64亿元,换手率1.12%,振幅2.18%,量比1.09。华海药业今日主力资金净流入1217万元,上一交易日主力净流入97万元,今日环比增加1154.64%。|04月29日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|宜通世纪|5.75%|#|*ST嘉寓|4.27%|#|昊志机电|3.66%|#|宝利国际|3.26%|#|天晟新材|3.08%|#|日盈电子|2.87%|#|三六五网|2.78%|#|*ST名家|2.77%|#|德必集团|2.74%|#|中海达|2.71%|华海药业所在的化学制药行业,今日主力净流入5467万元,行业排名43/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042915213987bdf18c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042915213987bdf18c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430298426","title":"北向资金4月25日净买入华海药业5.75万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430298426","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430298426?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:30","pubTimestamp":1714095014,"startTime":"0","endTime":"0","summary":"4月25日, 北向资金增持华海药业5.75万股,连续3日增持。截止当日收盘,沪股通共持有华海药业3451.68万股,占流通股2.35%。沪股通增持金额前五个股分别为招商银行、中国平安、紫金矿业、中控技术、中信证券。华海药业近5个交易日上涨5.32%,沪股通累计减持117.80万股;近20个交易日上涨21.85%,沪股通累计增持6.83万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260931228b54f181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260931228b54f181&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429048850","title":"华海药业04月24日遭主力抛售2595万元 环比增加921.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429048850","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429048850?lang=zh_cn&edition=full","pubTime":"2024-04-24 15:17","pubTimestamp":1713943067,"startTime":"0","endTime":"0","summary":"04月24日,华海药业股价收平报15.69元,成交金额1.57亿元,换手率0.69%,振幅1.53%,量比0.56。华海药业今日主力资金净流出2595万元,连续5日净流出,上一交易日主力净流出254万元,今日环比增加921.65%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为57.14%,平均跌幅为1.71%。该股近5个交易日上涨3.50%,主力资金累计净流出3976万元;近20日主力资金累计净流出7453万元,其中净流出天数为14日。净流出前三个股分别为新和成、华海药业、贝达药业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042415203787a99c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042415203787a99c85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429164513","title":"华海药业(600521.SH)获“白消安注射液”药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429164513","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429164513?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:12","pubTimestamp":1713867145,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)公告,公司于近日收到国家药品监督管理局(“国家药监局”)核准签发的白消安注射液的《药品注册证书》。据悉,白消安注射液适用于联合环磷酰胺,作为慢性髓性白血病同种异体的造血祖细胞移植前的预处理方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107660.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429161029","title":"华海药业最新公告:获得白消安注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429161029","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429161029?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:00","pubTimestamp":1713866410,"startTime":"0","endTime":"0","summary":"华海药业公告,获得白消安注射液药品注册证书。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300035354.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428458356","title":"超级真菌概念盘中跳水,海正药业跌0.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428458356","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428458356?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:38","pubTimestamp":1713404295,"startTime":"0","endTime":"0","summary":"04月18日,超级真菌概念盘中跳水,截至09点38分,超级真菌概念整体指数下跌0.69%,报727.100点。从个股上来看,该概念的成分股中,海正药业跌0.80%,哈药股份、联环药业、华海药业跌幅居前。从资金上来看,截止发稿,超级真菌概念主力净流入为-2575.48万,其中华海药业受到资金热捧,主力净流入193.90万;拉长时间线来看,该板块近20日主力资金净流入-14.14亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809381587e817aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809381587e817aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427812222","title":"华海药业(600521.SH)获得托拉塞米片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2427812222","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2427812222?lang=zh_cn&edition=full","pubTime":"2024-04-16 16:16","pubTimestamp":1713255360,"startTime":"0","endTime":"0","summary":"华海药业发布公告,公司于近日收到国家药品监督管理局核准签发的托拉塞米片的《药品注册证书》。托拉塞米片获得国家药监局的《药品注册证书》,进一步丰富了公司的产品线,有助于提升公司产品的市场竞争力。根据国家相关政策,公司托拉塞米片按化学药品4类批准生产可视同通过一致性评价,医疗机构将会优先采购并在临床中优先选用,对公司的经营业绩产生积极的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-16/doc-inarziqs2542441.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-16/doc-inarziqs2542441.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427881666","title":"华海药业04月16日遭主力抛售3115万元 环比增加775.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427881666","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427881666?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:17","pubTimestamp":1713251858,"startTime":"0","endTime":"0","summary":"04月16日, 华海药业股价跌0.27%,报收14.76元,成交金额4.47亿元,换手率2.03%,振幅4.46%,量比1.01。华海药业今日主力资金净流出3115万元,连续3日净流出,上一交易日主力净流出356万元,今日环比增加775.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为66.67%,平均跌幅为1.57%。该股近5个交易日上涨11.90%,主力资金累计净流出4469万元;近20日主力资金累计净流出6781万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161522038b295e53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161522038b295e53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427862746","title":"高血压概念盘中拉升,华海药业涨1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427862746","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427862746?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:54","pubTimestamp":1713236041,"startTime":"0","endTime":"0","summary":"04月16日,高血压概念盘中拉升,截至10点53分,高血压概念整体指数上涨0.53%,报909.250点。从个股上来看,该概念的成分股中,华海药业涨1.22%,普洛药业、鱼跃医疗涨幅居前。从资金上来看,截止发稿,高血压概念主力净流入为-5752.98万,其中方盛制药受到资金热捧,主力净流入375.79万;拉长时间线来看,该板块近20日主力资金净流入-3.74亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161054017a5305bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161054017a5305bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427078765","title":"华海药业:预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427078765","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2427078765?lang=zh_cn&edition=full","pubTime":"2024-04-15 18:00","pubTimestamp":1713175233,"startTime":"0","endTime":"0","summary":"证券之星消息,华海药业发布业绩预告,预计2024年1-3月归属净利润盈利2.6亿元至2.85亿元。华海药业2023年三季报显示,公司主营收入62.08亿元,同比上升6.33%;归母净利润7.22亿元,同比下降9.18%;扣非净利润7.69亿元,同比下降8.29%;其中2023年第三季度,公司单季度主营收入19.13亿元,同比下降5.02%;单季度归母净利润1.53亿元,同比下降32.57%;单季度扣非净利润1.47亿元,同比下降42.34%;负债率55.21%,投资收益-5480.12万元,财务费用6749.99万元,毛利率58.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415180136877f012d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415180136877f012d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427229010","title":"华海药业(600521.SH):2023年度净利润8.26亿元 同比下降29.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427229010","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2427229010?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:30","pubTimestamp":1713173431,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)披露2023年度业绩快报,该公司报告期实现营业总收入83.09亿元,同比增长0.52%。归属于上市公司股东的净利润8.26亿元,同比下降29.25%。归属于上市公司股东的扣除非经常性损益的净利润8.98亿元,同比下降22.08%。基本每股收益为0.57元/股。报告期内,该公司业绩下滑,主要是:原料药业务方面:受全球经济增速放缓、各国本土化政策推进等因素影响,原料药行业竞争加剧,部分产品价格下降影响公司利润减少。制剂业务方面:随着国内集采政策的持续深化,集采产品价格进一步下降影响公司利润进一步缩减。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415174110877eed64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415174110877eed64&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024418","title":"华海药业(600521.SH):2023年净利润同比下降29.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024418","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427024418?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:21","pubTimestamp":1713172908,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨华海药业(600521.SH)公布2023年度业绩快报,经初步核算,公司2023年度实现营业收入830,871.98万元,同比增长0.52%,实现归属于上市公司股东的净利润82,621.68万元,同比下降29.25%,其中归属于上市公司股东的扣除非经常性损益的净利润89,846.90万元,同比下降22.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415172159877edc85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415172159877edc85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427244900","title":"华海药业(600521.SH):恩格列净片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2427244900","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2427244900?lang=zh_cn&edition=full","pubTime":"2024-04-15 17:20","pubTimestamp":1713172853,"startTime":"0","endTime":"0","summary":"格隆汇4月15日丨华海药业(600521.SH)公布,近日收到国家药品监督管理局核准签发的恩格列净片的《药品注册证书》,恩格列净片用于治疗2型糖尿病和心力衰竭成人患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151721028b256a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151721028b256a18&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2003-03-04","address":"浙江省台州市临海市汛桥","stockEarnings":[{"period":"1week","weight":0.0559},{"period":"1month","weight":0.2559},{"period":"3month","weight":0.2432},{"period":"6month","weight":0.0165},{"period":"1year","weight":-0.169},{"period":"ytd","weight":0.0941}],"companyName":"浙江华海药业股份有限公司","boardCode":"AI0027","perCapita":"20284股","boardName":"医药制造业","registeredCapital":"148250万元","compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0613},{"period":"6month","weight":0.0235},{"period":"1year","weight":-0.06},{"period":"ytd","weight":0.0382}],"survey":" 浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月,公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”,同月,公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地;2023年6月,公司入选米内网颁发的2022年度中国化药企业百强等。","serverTime":1714403444395,"listedPrice":15.55,"stockholders":"72310人(较上一季度减少1.88%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华海药业,600521,华海药业股票,华海药业股票老虎,华海药业股票老虎国际,华海药业行情,华海药业股票行情,华海药业股价,华海药业股市,华海药业股票价格,华海药业股票交易,华海药业股票购买,华海药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}